123 related articles for article (PubMed ID: 10883895)
1. CD44s, CD44v5 and CD44v6 protein contents in colorectal cancer and surrounding mucosa.
Llaneza A; Gonzalez A; Andicoechea A; Fernandez JC; Allende MT; García-Muñiz JL; Vizoso F
Int J Biol Markers; 2000; 15(2):192-4. PubMed ID: 10883895
[No Abstract] [Full Text] [Related]
2. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
[TBL] [Abstract][Full Text] [Related]
3. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
Liu YJ; Yan PS; Li J; Jia JF
World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
[TBL] [Abstract][Full Text] [Related]
4. CD44 expression in colorectal cancer.
Weg-Remers S; Schüder G; Zeitz M; Stallmach A
Ann N Y Acad Sci; 1998 Nov; 859():304-6. PubMed ID: 9928409
[No Abstract] [Full Text] [Related]
5. Proteome study of colorectal carcinogenesis.
Stulík J; Hernychová L; Porkertová S; Knízek J; Macela A; Bures J; Jandik P; Langridge JI; Jungblut PR
Electrophoresis; 2001 Aug; 22(14):3019-25. PubMed ID: 11565796
[TBL] [Abstract][Full Text] [Related]
6. [CYFRA 21.1 cytosol levels in lung adenocarcinomas. Correlation with other clinico-biological parameters].
Ruibal A; Núñez MI; Del Río MC; Lapeña G; Rodríguez J
Rev Esp Med Nucl; 2002; 21(5):333-7. PubMed ID: 12236907
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of CD44 variants expression in colorectal cancer.
Li XD; Ji M; Wu J; Jiang JT; Wu CP
Tumori; 2013; 99(1):88-92. PubMed ID: 23549006
[TBL] [Abstract][Full Text] [Related]
9. CD44 expression in benign and malignant colorectal polyps.
Neumayer R; Rosen HR; Reiner A; Sebesta C; Schmid A; Tüchler H; Schiessel R
Dis Colon Rectum; 1999 Jan; 42(1):50-5. PubMed ID: 10211520
[TBL] [Abstract][Full Text] [Related]
10. Significance of MUC1 and MUC2 mucin expression in colorectal cancer.
Ajioka Y; Allison LJ; Jass JR
J Clin Pathol; 1996 Jul; 49(7):560-4. PubMed ID: 8813954
[TBL] [Abstract][Full Text] [Related]
11. CD44V6 in gastric carcinoma: a marker of tumor progression.
Xin Y; Grace A; Gallagher MM; Curran BT; Leader MB; Kay EW
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):138-42. PubMed ID: 11396631
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.
Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A
J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan.
Kuo MY; Cheng SJ; Chen HM; Kok SH; Hahn LJ; Chiang CP
J Oral Pathol Med; 1998 Oct; 27(9):428-33. PubMed ID: 9790096
[TBL] [Abstract][Full Text] [Related]
14. [Cytosolic pS2 levels in 154 non-small-cell lung carcinomas. Correlation with other clinical and biological parameters].
Ruibal A; Núñez MI; del Río MC; García Díez S; Rodríguez J; Alvarez De Linera JA
Rev Esp Med Nucl; 2002 Apr; 21(2):109-14. PubMed ID: 11879619
[TBL] [Abstract][Full Text] [Related]
15. Correlation of CD44v6 expression with ovarian cancer progression and recurrence.
Shi J; Zhou Z; Di W; Li N
BMC Cancer; 2013 Apr; 13():182. PubMed ID: 23565736
[TBL] [Abstract][Full Text] [Related]
16. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
[TBL] [Abstract][Full Text] [Related]
17. Escherichia coli heat-stable enterotoxin receptors. A novel marker for colorectal tumors.
Carrithers SL; Parkinson SJ; Goldstein SD; Park PK; Urbanski RW; Waldman SA
Dis Colon Rectum; 1996 Feb; 39(2):171-81. PubMed ID: 8620784
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
Slebos RJ; Baas IO; Clement M; Polak M; Mulder JW; van den Berg FM; Hamilton SR; Offerhaus GJ
Br J Cancer; 1996 Jul; 74(2):165-71. PubMed ID: 8688317
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD44 isoforms correlates with the metastatic potential of osteosarcoma.
Kim HS; Park YB; Oh JH; Jeong J; Kim CJ; Lee SH
Clin Orthop Relat Res; 2002 Mar; (396):184-90. PubMed ID: 11859242
[TBL] [Abstract][Full Text] [Related]
20. Ki67 immunohistochemical evaluation in colorectal cancer and normal colonic mucosa. Possible clinical applications.
Berenzi A; Benetti A; Bertalot G; Rodolfi A; Portolani N; Giulini SM; Pulcini G; Vinco A; Tiberio G
Pathologica; 1992; 84(1090):155-63. PubMed ID: 1437304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
